Should Hybrid Closed-Loop Insulin Delivery Be Used During Pregnancy?

Should Hybrid Closed-Loop Insulin Delivery Be Used During Pregnancy? | Recording

Recorded Webinar

This webinar will discuss the development and current limitations for using HCL technology in pregnancy.

Overview

Preexisting diabetes in pregnancy is associated with increased risk for adverse perinatal and neonatal outcomes. It is critical to reduce these risks by achieving well-controlled blood glucose levels without increasing maternal hypoglycemia. However, maintaining tight glycemic control is challenging in the setting of rapid metabolic, physiologic, and anatomic changes throughout gestation. The development and rapid improvement of continuous glucose monitoring technology has allowed significant progress toward hybrid closed-loop (HCL) insulin delivery systems, but there are current limitations for using HCL technology in pregnancy. The speakers, Sarit Polsky, MD, MPH and Amy Valent, DO, MCR, discuss these challenges and more.

Summary


Availability:	On-Demand
	Expires on 01/24/2025


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account